Marian Brock-Andersen
Endocrinology, Diabetes & Metabolism · Phoenix, AZNPI 1346927365
Payments from drug & device makers
Across 110 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$443
- AstraZeneca$358
- Novo Nordisk$227
- Lilly USA, LLC$151
- Otsuka America Pharmaceutical, Inc.$123
- Amgen$69
- plus $531 from 16 others
What the payments were for
- Food & beverage$1,902100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $443 |
| AstraZeneca | 10 | $358 |
| Novo Nordisk | 8 | $227 |
| Lilly USA, LLC | 11 | $151 |
| Otsuka America Pharmaceutical, Inc. | 6 | $123 |
| Amgen | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Boehringer Ingelheim | 3 | $57 |
| Exact Sciences | 2 | $54 |
| GSK | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Hologic Sales And Service, LLC | 1 | $36 |
| Lundbeck LLC | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| Dexcom, Inc. | 1 | $25 |
| Si-bone, Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,902 in reported general payments places this provider in the 40th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $38,164 |
| RexultiBrexpiprazole | 13 | $19,943 |
| MounjaroTirzepatide | 14 | $14,823 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,953 |
| JardianceEmpagliflozin | 11 | $8,333 |
| FarxigaDapagliflozin Propanediol | 11 | $5,758 |
| PaxlovidNirmatrelvir/Ritonavir | 17 | $1,429 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,118 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $857 |
| Methylprednisolone | 74 | $551 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 37 | $526 |
| Fluticasone Propionate | 38 | $500 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $426 |
| Cephalexin | 26 | $420 |
| Gabapentin | 34 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $227 | $38,16436 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $123 | $19,94313 claims |
| Lilly USA, LLCMounjaro | $151 | $14,82314 claims |
| GSKTrelegy Ellipta | $49 | $9,95311 claims |
| Boehringer IngelheimJardiance | $57 | $8,33311 claims |
| AstraZenecaFarxiga | $358 | $5,75811 claims |
| PfizerPaxlovid | $21 | $1,42917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Phoenix
- Kevin YuenPhoenix$733K
- Joan BaileyPhoenix$316K
- Peter ReavenPhoenix$142K
- Sherman HarmanPhoenix$47K
- Anna BoronPhoenix$32K
- Kari EdlingPhoenix$23K
- Richard ArakakiPhoenix$20K
- James DeerPhoenix$13K
- Lory BarazPhoenix$10K
- Sathya JyothinagaramPhoenix$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.